Cargando…
Medical Care and Long-Term Care Expenditures Attributable to Alzheimer’s Disease Onset: Results from the LIFE Study
BACKGROUND: Alzheimer’s disease (AD) can increase both medical care and long-term care (LTC) costs, but the latter are frequently neglected in estimates of AD’s economic burden. OBJECTIVE: To elucidate the economic burden of new AD cases in Japan by estimating patient-level medical care and LTC expe...
Autores principales: | Fukuda, Haruhisa, Ono, Rei, Maeda, Megumi, Murata, Fumiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8673503/ https://www.ncbi.nlm.nih.gov/pubmed/34602465 http://dx.doi.org/10.3233/JAD-201508 |
Ejemplares similares
-
Anti-Dementia Drug Persistence Following Donepezil Initiation Among Alzheimer’s Disease Patients in Japan: LIFE Study
por: Fukuda, Haruhisa, et al.
Publicado: (2022) -
Disease Burden and Progression in Patients with New-Onset Mild Cognitive Impairment and Alzheimer’s Disease Identified from Japanese Claims Data: Evidence from the LIFE Study
por: Fukuda, Haruhisa, et al.
Publicado: (2023) -
Acute and delayed psychiatric sequelae among patients hospitalised with COVID-19: a cohort study using LIFE study data
por: Murata, Fumiko, et al.
Publicado: (2022) -
Effect of COVID-19 Vaccination on Household Transmission of SARS-CoV-2 in the Omicron Era: The Vaccine Effectiveness, Networking, and Universal Safety (VENUS) study
por: Maeda, Megumi, et al.
Publicado: (2023) -
Development of a COVID-19 vaccine effectiveness and safety assessment system in Japan: The VENUS study
por: Fukuda, Haruhisa, et al.
Publicado: (2023)